人工智能驱动的药物发现用于罕见疾病
Amit Gangwal1, Antonio Lavecchia2
1Department of Natural Product Chemistry, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.
Journal of chemical information and modeling
|December 17, 2024
概括
人工智能 (AI) 为罕见疾病 (RDs) 提供了变革性的解决方案,加速了药物发现和开发. 人工智能驱动的方法有望克服治疗这些复杂疾病的挑战,改善患者的治疗结果.
科学领域:
- 医学研究 医学研究
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 罕见疾病 (RDs) 在全球影响3亿,其中90%以上缺乏有效的治疗方法.
- 由于复杂性和投资回报低,传统药物发现在R&D方面面临重大障碍.
- 现有的立法努力还没有充分解决大多数RDs的治疗缺口.
研究的目的:
- 探索人工智能 (AI) 在加速罕见疾病 (RDs) 药物发现方面的革命性潜力.
- 审查人工智能驱动的进展,以应对研发和开发治疗开发的挑战.
- 综合当前的知识,并指导未来的人工智能研发领域的研发.
主要方法:
- 审查AI在药物发现中的应用,包括机器学习 (ML) 和深度学习 (DL).
- 分析人工智能在药物重定位,生物标志物发现和个人化药物研发研究中的作用.
- 检查人工智能在遗传学,临床试验优化和新药标识中的应用.
主要成果:
- 人工智能显示出克服传统药物发现局限性的巨大潜力.
- 人工智能有助于在识别新药标和优化临床试验方面取得进展.
- 人工智能驱动的策略,如药物重定向和个性化医疗,对研发和开发人员来说是有前途的.
结论:
- 人工智能对于改变罕见疾病的研究和开发至关重要.
- 人工智能加速了治疗的发展,为改善RDS患者的治疗结果提供了希望.
- 本次审查强调了人工智能在解决罕见疾病未满足的医疗需求方面发挥的关键作用.
相关概念视频
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Prescription, Nonprescription and Orphan Drugs
687
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
687
Structure-Activity Relationships and Drug Design
510
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
510
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K


